合富輝煌(00733.HK)上半年股東應占虧損達4.87億港元
格隆匯8月26日丨合富輝煌(00733.HK)發佈公吿,截至2022年6月30日止六個月,集團的營業額為29.74億港元,與去年同期比較下跌約24%;股東應占虧損達4.87億港元(2021年:股東應占溢利為3300萬港元),其中包括商譽減值約2.06億港元。每股基本虧損為72.26港仙。
期內,集團物業代理業務分部營業額為29.38億港元,佔集團總營業額的99%;金融服務業務的營業額約3600萬港元,佔集團總營業額的1%。集團於2022年上半年新屋銷售金額約2,830億港元,總銷售面積約1500萬平方米。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.